Upgrade Of 2024 Full-Year Guidance

PolyPeptide AG

13/08/2024 06:08

Aug 13 (Reuters) - POLYPEPTIDE GROUP AG  PPGN.S :
    * SOLID PROGRESS IN H1 2024 – UPGRADE OF 2024 FULL-YEAR
GUIDANCE –
MID-TERM TARGET TO DOUBLE 2023 REVENUE BY 2028
    * NEW MID-TERM OUTLOOK: TARGET TO DOUBLE REVENUE REPORTED
FOR 2023
BY 2028
    * 2024: NOW EXPECTING HIGH SINGLE-DIGIT REVENUE GROWTH
VERSUS 2023
AT CONSTANT CURRENCY RATES WITH POSITIVE MID SINGLE-DIGIT EBITDA
MARGIN, OPERATING AT A NET LOSS
    * EBITDA MARGIN EXPECTED TO APPROACH 25% BY 2028
    * CAPITAL EXPENDITURES OF 15% TO 20% OF REVENUE REQUIRED TO
ENSURE
CAPACITY ALSO BEYOND 2028

Source text for Eikon:  ID:nEQ7F6WNLa 
Further company coverage:  PPGN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com))